Plante Moran Financial Advisors’s Phibro Animal Health PAHC Stock Holding History

Plante Moran Financial Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$63	Buy	+2	New	+$84	﹤0.01%	1571

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HAI

Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

CCMINC

Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $826M AUM 32.06% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Plante Moran Financial Advisors's PAHC Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in Phibro Animal Health (PAHC) in Q2 2026: 2 shares worth $63. The stake represents ﹤0.01% of the portfolio and ranks #1571 among its holdings.

78 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Plante Moran Financial Advisors held 2 shares of Phibro Animal Health worth $63 as of Q2 2026.
Phibro Animal Health was a new Plante Moran Financial Advisors position in Q2 2026.
Phibro Animal Health made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #1571 holding.
78 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.